Can Tumor Necrosis Factor- &#945; and Interleukin-6 Be Used as Prognostic Markers of Infection following Ureteroscopic Lithotripsy?

Bantis, Athanasios; Tsakaldimis, Georgios; Zissimopoulos, Athanasios; Giannakopoulos, Stilianos; Kalaitzis, Christos; Pitiakoudis, Michail; Polichronidis, Alexandros; Touloupidis, Stavros

Can Tumor Necrosis Factor- α and Interleukin-6 Be Used as Prognostic Markers of Infection following Ureteroscopic Lithotripsy?

Bantis, Athanasios; Tsakaldimis, Georgios; Zissimopoulos, Athanasios; Giannakopoulos, Stilianos; Kalaitzis, Christos; Pitiakoudis, Michail; Polichronidis, Alexandros; Touloupidis, Stavros.

Afiliação

Bantis A; Urology Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Tsakaldimis G; Urology Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Zissimopoulos A; Nuclear Medicine Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Giannakopoulos S; Urology Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Kalaitzis C; Urology Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Pitiakoudis M; General Surgery Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Polichronidis A; General Surgery Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.
Touloupidis S; Urology Department, University Hospital of Alexandroupolis, 68100 Thrace, Greece.

ISRN Urol ; 2014: 457063, 2014.

Article em En | MEDLINE | ID: mdl-24605247

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: ISRN Urol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google